| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard. |
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
Eric Joseph Rubin (born 1958) is an American microbiologist and infectious disease specialist1. He is a Professor of Medicine at Harvard Medical School, an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and the Editor-in-Chief of the New England Journal of Medicine2 and NEJM Group.
Personal life Rubin was born and raised in Brockton, Massachusetts. His father, Morris Rubin, was a salesman and his mother, Paula (Schechet) Rubin, was a school librarian. He is married to Akiyo Fujii and has two children, Alexander and Daniel.
Education and career Rubin graduated from Brockton High School, Harvard College (AB, 1980) and Tufts University (MD and PhD, 1990).7 As a graduate student he studied the mechanism of action of botulinum toxins with D. Michael Gill. Rubin trained in Internal Medicine and Infectious Disease at the Massachusetts General Hospital and went on to postdoctoral work in John Mekalanos’ lab at Harvard Medical School.3,4 There he studied Vibrio cholerae, Haemophilus influenzae and Mycobacterium smegmatis. His postdoctoral work included collaborating on the development of a widely used transposition system based on the Himar1 transposon along with the methods for mapping mutations on a genome-wide basis.
Rubin joined the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health in 1999, eventually becoming the Irene Heinz Given Professor and Chair of the Department. His lab studies mycobacterial physiology and virulence and has developed many of the genetic tools used to study Mycobacterium tuberculosis5 and related organisms. With collaborators, the lab has used these tools to address a wide range of questions about tuberculosis pathogenesis, non-tuberculous mycobacteria, and drug and vaccine development. 6 He is also an infectious disease clinician who sees patients at Brigham and Women’s Hospital, where he is an Associate Physician.
In 2019, Rubin was appointed Editor-in-Chief of the Journal, where he had previously served as an Associate Editor, and NEJM Group, the publishing division of the Massachusetts Medical Society. During the Covid-19 outbreak, the Journal added a weekly podcast9 and rapidly published many studies, including the first description of SARS-CoV-2, the causative virus. During Rubin’s tenure, NEJM Group has also launched two more publications, NEJM Evidence and NEJM AI.
Rubin has worked extensively in international settings and has been involved on advisory boards for several national and global organizations. He is a member of the American Academy of Microbiology, the American Association of Physicians, and the National Academy of Medicine. He also serves on the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).10
References
Dawn-NEJMGroup (talk) 14:14, 31 May 2024 (UTC)[reply]
 | The user below has a request that an edit be made to Eric Rubin. That user has an actual or apparent conflict of interest. The requested edits backlog is high. Please be very patient. There are currently 172 requests waiting for review. Please read the instructions for the parameters used by this template for accepting and declining them, and review the request below and make the edit if it is well sourced, neutral, and follows other Wikipedia guidelines and policies. |
